Evidence map›Paper›PMID 38250328›Full record

ReviewFrontiers in cell and developmental biology2023

An extensive review on phenolic compounds and their potential estrogenic properties on skin physiology.

Francesca Rispo, Giulia De Negri Atanasio, Ilaria Demori, Giosuè Costa, Emanuela Marchese, Simón Perera-Del-Rosario, Eva Serrano-Candelas, Martina Palomino-Schätzlein, Elisabetta Perata, Federica Robino and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. RSC advances · 2024
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Francesca Rispo *Department of Earth, Environment and Life Science, University of Genoa, Genova, Italy.
Giulia De Negri Atanasio *Department of Earth, Environment and Life Science, University of Genoa, Genova, Italy.
Ilaria DemoriDepartment of Pharmacy, University of Genoa, Genova, Italy.
Giosuè CostaDepartment of Health Sciences, University "Magna Graecia", Catanzaro, Italy.
Emanuela MarcheseDepartment of Health Sciences, University "Magna Graecia", Catanzaro, Italy.
Simón Perera-Del-RosarioProtoQSAR SL, Centro Europeo de Empresas Innovadoras (CEEI), Parque Tecnológico de Valencia, Valencia, Spain.
Eva Serrano-CandelasProtoQSAR SL, Centro Europeo de Empresas Innovadoras (CEEI), Parque Tecnológico de Valencia, Valencia, Spain.
Martina Palomino-SchätzleinMoldrug AI Systems S.L, Valencia, Spain.
Elisabetta PerataAngel Consulting S.a.s 20122 Milano, Milano, Italy.
Federica RobinoAngel Consulting S.a.s 20122 Milano, Milano, Italy.
Pier Francesco FerrariDepartment of Civil, Chemical and Environmental Engineering, University of Genoa, Genova, Italy.
Sara FerrandoDepartment of Earth, Environment and Life Science, University of Genoa, Genova, Italy.
Silvia LetasiovaMatTek In Vitro Life Science Laboratories, Bratislava, Slovakia.
Jan MarkusMatTek In Vitro Life Science Laboratories, Bratislava, Slovakia.
Matteo Zanotti-RussoAngel Consulting S.a.s 20122 Milano, Milano, Italy.
Elena GrasselliDepartment of Earth, Environment and Life Science, University of Genoa, Genova, Italy.
University of Genoa · ITMagna Graecia University · ITMatTek (Slovakia) · SKPompeu Fabra University · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyphenolic compounds constitute a diverse group of natural components commonly occurring in various plant species, known for their potential to exert both beneficial and detrimental effects. Additionally, these polyphenols have also been implicated as endocrine-disrupting (ED) chemicals, raising concerns about their widespread use in the cosmetics industry. In this comprehensive review, we focus on the body of literature pertaining to the estrogenic properties of ED chemicals, with a particular emphasis on the interaction of isoflavones with estrogen receptors. Within this review, we aim to elucidate the multifaceted roles and effects of polyphenols on the skin, exploring their potential benefits as well as their capacity to act as ED agents. By delving into this intricate subject matter, we intend to provoke thoughtful consideration, effectively opening a Pandora's box of questions for the reader to ponder. Ultimately, we invite the reader to contemplate whether polyphenols should be regarded as friends or foes in the realm of skincare and endocrine disruption.

Indexed as

antioxidantcosmeticsdaidzeinendocrine disruptorsestrogengenisteinpolyphenolsskin physiology

Identifiers

PMID38250328
PMCPMC10798251
OpenAlexW4390585193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.